OBJECTIVES: Murine erythroblasts infected with the anemia-inducing strain of Friend virus (FVA cells) terminally differentiate to the reticulocyte stage after 48 hours of culture in vitro in response to erythropoietin (EPO). The objective of this study was to determine the possible role of proteasome-mediated proteolysis during the terminal differentiation of FVA cells. MATERIALS AND METHODS: The proteasome inhibitors MG132 and lactacystin were used to perturb the normal function of proteasomes during terminal differentiation. Effects of proteasome inhibitors on terminal differentiation were quantitated by evaluation of cellular morphology after benzidine staining and by Western blot analyses. RESULTS: Treatment of EPO-stimulated FVA cells with lactacystin or MG132 at later periods of culture increased accumulations of nuclear and cytosolic ubiquitinated proteins and decreased nuclear extrusion to less than 40% of controls. CONCLUSIONS: Our results suggest that the proteasomal degradation of ubiquitinated proteins plays an important role in the enucleation of mammalian erythroblasts.
OBJECTIVES:Murine erythroblasts infected with the anemia-inducing strain of Friend virus (FVA cells) terminally differentiate to the reticulocyte stage after 48 hours of culture in vitro in response to erythropoietin (EPO). The objective of this study was to determine the possible role of proteasome-mediated proteolysis during the terminal differentiation of FVA cells. MATERIALS AND METHODS: The proteasome inhibitors MG132 and lactacystin were used to perturb the normal function of proteasomes during terminal differentiation. Effects of proteasome inhibitors on terminal differentiation were quantitated by evaluation of cellular morphology after benzidine staining and by Western blot analyses. RESULTS: Treatment of EPO-stimulated FVA cells with lactacystin or MG132 at later periods of culture increased accumulations of nuclear and cytosolic ubiquitinated proteins and decreased nuclear extrusion to less than 40% of controls. CONCLUSIONS: Our results suggest that the proteasomal degradation of ubiquitinated proteins plays an important role in the enucleation of mammalian erythroblasts.
Authors: S Koury; S Yarlagadda; K Moskalik-Liermo; N Popli; N Kim; C Apolito; A Peterson; X Zhang; P Zu; J Tamburlin; D Bofinger Journal: Genomics Date: 2007-08-31 Impact factor: 5.736
Authors: Steven Bergink; Arjan F Theil; Wendy Toussaint; Iris M De Cuyper; Divine I Kulu; Thomas Clapes; Reinier van der Linden; Jeroen A Demmers; Eric P Mul; Floris P van Alphen; Jurgen A Marteijn; Teus van Gent; Alex Maas; Catherine Robin; Sjaak Philipsen; Wim Vermeulen; James R Mitchell; Laura Gutiérrez Journal: Mol Cell Biol Date: 2013-07-29 Impact factor: 4.272
Authors: Christopher S Thom; Elizabeth A Traxler; Eugene Khandros; Jenna M Nickas; Olivia Y Zhou; Jacob E Lazarus; Ana P G Silva; Dolly Prabhu; Yu Yao; Chiaka Aribeana; Serge Y Fuchs; Joel P Mackay; Erika L F Holzbaur; Mitchell J Weiss Journal: Dev Cell Date: 2014-09-18 Impact factor: 12.270
Authors: Irene Artuso; Maria Rosa Lidonnici; Sandro Altamura; Giacomo Mandelli; Mariateresa Pettinato; Martina U Muckenthaler; Laura Silvestri; Giuliana Ferrari; Clara Camaschella; Antonella Nai Journal: Blood Date: 2018-09-12 Impact factor: 22.113
Authors: Christina B Wölwer; Luke B Pase; Helen B Pearson; Nathan J Gödde; Kurt Lackovic; David C S Huang; Sarah M Russell; Patrick O Humbert Journal: PLoS One Date: 2015-11-16 Impact factor: 3.240